Evidence map›Paper›PMID 31131347›Full record

ArticleJBMR plus2019

Discogenic Back Pain: Literature Review of Definition, Diagnosis, and Treatment.

Kengo Fujii, Masashi Yamazaki, James D Kang, Makarand V Risbud, Samuel K Cho, Sheeraz A Qureshi, Andrew C Hecht, James C Iatridis

Registry-linked trialAbstract read
In one paragraph

Article in JBMR plus, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06703671 (The Efficacy and Safety of Electroacupuncture Compared With Sham Acupuncture in Patients With Discogenic Low Back Pain), which is not on this map. Cited by 103 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06703671 narecruitingnot on this mapstarted 2025, after this paper: background citation

The Efficacy and Safety of Electroacupuncture Compared With Sham Acupuncture in Patients With Discogenic Low Back Pain: A Multicenter Randomized Controlled Trial

TypeinterventionalSponsorBeijing HospitalRan2025 to 2026Enrolled240ConditionsDiscogenic Low Back PainArmselectroacupuncture group, sham-acupuncture group
3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kengo FujiiLeni & Peter W. May Department of Orthopaedics Icahn School of Medicine at Mount Sinai New York NY USA.
Masashi YamazakiDepartment of Orthopaedic Surgery University of Tsukuba Tsukuba Japan.
James D KangDepartment of Orthopaedic Surgery Brigham and Women's Hospital Harvard Medical School Boston MA USA.
Makarand V RisbudDepartment of Orthopaedic Surgery Sidney Kimmel Medical College Thomas Jefferson University Philadelphia PA USA.
Samuel K ChoLeni & Peter W. May Department of Orthopaedics Icahn School of Medicine at Mount Sinai New York NY USA.
Sheeraz A QureshiDepartment of Orthopaedic Surgery Hospital for Special Surgery New York NY USA.
Andrew C HechtLeni & Peter W. May Department of Orthopaedics Icahn School of Medicine at Mount Sinai New York NY USA.
James C IatridisLeni & Peter W. May Department of Orthopaedics Icahn School of Medicine at Mount Sinai New York NY USA.

Funding

Role of HIF-1 in Intervertebral Disc FunctionR01AR055655 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI RISBUD, MAKARAND V · 2008 to 2023
$6.1M
Model of Human Disc Regeneration in the spectrum of Degenerative Disc DiseaseR01AR057397 · NIAMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI IATRIDIS, JAMES C. · 2011 to 2021
$5.1M
Diabetes Induced Disc Degeneration and PreventionR01AR069315 · NIAMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI IATRIDIS, JAMES C. · 2016 to 2020
$2.7M
Notochordal Cell Derived Therapies for Painful Disc DegenerationR01AR064157 · NIAMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI IATRIDIS, JAMES C. · 2013 to 2017
$2.7M
Disruption of Osmoregulation Promotes Degenerative Disc DiseaseR01AR064733 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI RISBUD, MAKARAND V, SHAPIRO, IRVING M · 2014 to 2018
$2.4M
NIAMS NIH HHS R01 AR055655NIAMS NIH HHS R01 AR057397NIAMS NIH HHS R01 AR064157NIAMS NIH HHS R01 AR064733NIAMS NIH HHS R01 AR069315
6 · The paper itself

Abstract

Discogenic back pain is multifactorial; hence, physicians often struggle to identify the underlying source of the pain. As a result, discogenic back pain is often hard to treat-even more so when clinical treatment strategies are of questionable efficacy. Based on a broad literature review, our aim was to define discogenic back pain into a series of more specific and interacting pathologies, and to highlight the need to develop novel approaches and treatment strategies for this challenging and unmet clinical need. Discogenic pain involves degenerative changes of the intervertebral disc, including structural defects that result in biomechanical instability and inflammation. These degenerative changes in intervertebral discs closely intersect with the peripheral and central nervous systems to cause nerve sensitization and ingrowth; eventually central sensitization results in a chronic pain condition. Existing imaging modalities are nonspecific to pain symptoms, whereas discography methods that are more specific have known comorbidities based on intervertebral disc puncture and injection. As a result, alternative noninvasive and specific diagnostic methods are needed to better diagnose and identify specific conditions and sources of pain that can be more directly treated. Currently, there are many treatments/interventions for discogenic back pain. Nevertheless, many surgical approaches for discogenic pain have limited efficacy, thus accentuating the need for the development of novel treatments. Regenerative therapies, such as biologics, cell-based therapy, intervertebral disc repair, and gene-based therapy, offer the most promise and have many advantages over current therapies. © 2019 The Authors.

Indexed as

DIAGNOSTIC CRITERIADISC DEGENERATIONDISCOGENIC BACK PAININTERVERTEBRAL DISCLOW BACK PAIN

Identifiers

PMID31131347
PMCPMC6524679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.